In this white paper, Robyn Woidtke MSN, RN, CCSH, RPSGT, FAAST. Aims to provide the dental sleep practitioner with a high-level overview of the technical, regulatory, and legal complexities of 3D printing a medical device at the Point of Care (PoC) and to assess how mandibular advancement devices (MADs) fit into this milieu.
“It’s a dangerous business, Frodo, going out your door. You step onto the road, and if you don’t keep your feet, there’s no knowing where you might be swept off to.” J.R.R. Tolkien, The Lord of the Rings.
As the quote above notes, it is essential to fully understand this complex issue before considering traveling down this road. This white paper aims to provide the dental sleep practitioner with a high-level overview of the technical, regulatory, and legal complexities of 3D printing a medical device at the Point of Care (PoC) and to assess how mandibular advancement devices (MADs) fit into this milieu.
There may be significant technological differences between printing a crown and a mandibular advancement device, understanding the nuances are important not only for the fabrication, but anyliability issues which are crucial when making purchasing and practice-related decisions.
Exploring 3D printed point of care medical devices/MAD:
- What is the current regulatory and quality climate for Class II MAD devices printed at PoC
- What should a dental provider be aware of when considering integrating a 3D PoC process at their facility?
- Is it really saving your practice time and money? And at what risk?
- Recommendations for Evaluation
Choosing the right device for your practice and patients should consider various factors and risk evaluation. This review is not comprehensive but rather summarizes the key factors to help make an informed decision regarding PoC 3D printing.
“Entities should understand their responsibilities – 3D printing at the PoC can raise confusion or ambiguity about who is responsible for a device’s total product life cycle. Entities should understand which requirements under the FD&C Act apply to them and their activities”. FDA1
The emergence of 3D printing in the medical field has seen enormous potential and growth. 3D printing is used for many dental device applications such as mandibular advancement devices, crowns, and implants. However, recent FDA correspondence (personal email (dated May 28, 2025) from the Division of Industry and Consumer Education (DICE)) indicated that, as of that date, there has not been a 3D PoC oral appliance that has 510k clearance.
New technology brings new opportunities and responsibilities, including considering PoC 3D printing. Dentists are currently using PoC printing for surgical guides, dentures, and aligners. However, the PoC printing of MAD may have additional regulatory implications.
“FDA does not regulate 3D printers themselves, but rather the manufacturing process and output of those printers if that output is a medical device” Pew.Org 2
3D printing, also known as additive manufacturing, can be integrated into many aspects of patient care and treatment. The concepts of personalized medical devices, which are often referred to as “patient-matched” are the outputs of additive manufacturing. The general 3D printing process is outlined in the figure below. There may be additional specific processes depending on the device.
The United States Food and Drug Administration (FDA) and other regulatory bodies regulate how medical devices are sold and distributed in their respective countries. According to the FDA, medical devices fall into one of three categories. Class 1 (lowest risk), Class II (medium risk), and Class III the highest risk for a product that includes implantable and life-sustaining products.
MAD fall under a Class II designation, which means that not only general controls such as labeling, establishment registration and device listing and quality system requirements for manufacturing are required, but FDA also has a special controls document “Intraoral Devices for Snoring and/or Obstructive Sleep Apnea – Class II Special Controls Guidance Document for Industry and FDA” for which manufacturing compliance is required. A special controls document outlines additional requirements beyond general controls, which are device-centric, as noted above. Such items may include specific labeling, testing, and biocompatibility.
Owners or operators of establishments that are involved in the production and distribution of medical devices intended for use in the U.S. are required to register annually with the FDA. This process is known as establishment registration (21 CFR Part 807). However, there may be an exemption for practitioners to register and list (21 CRF 807.65), but it would not necessarily exempt them from the other requirements, such as the quality system.
Recent correspondence with FDA’s, Center for Devices and Radiological Health (November 2025) indicates the following:
“If a dentist is using a legally marketed MDPS then she should be following the material and process specifications provided by the manufacturer. The manufacturer is responsible for 510(k), registration, listing, and QS. This is assuming that the dentist is using the system for patients within her practice.
Note, she may modify the device, as needed, solely for use in her practice (807.65(d)) but this is off label use within the practice of medicine. Although this would not classify the practitioner as a manufacturer (820.3(o)), she would assume liability if the device fails.
The practitioner would be a manufacturer and be subject to 510(k) (if not exempt), registration, listing, and QS if the following conditions are met: 1) she is engaged in activities defined in 807.20 and 2) she offers the device for introduction into U.S. interstate commerce for commercial distribution. If these criteria are not met, then she would not be considered a manufacturer or subject to 510(k), registration, listing, or QS”
The manufacturer should supply the dental practitioner with a unique device identifier (UDI) number, and the dental practitioner is required to maintain a record of the lot and UDI for the manufacturer. In essence, it may come down to a shared responsibility between the practitioner and the manufacturer of the materials and system.
Devices printed with 3D technology, including aspects of computer-aided design (CAD) and computer- aided manufacturing (CAM), are also required to comply with the regulations of each country. ISO 13485 is a globally recognized standard for quality systems for medical devices. Most countries, including the U.S., are moving toward this standard. Certification in this standard denotes high quality and assurance regarding the product development process. February 2, 2026 FDA moved to harmonize with ISO 13485 standard.
Under 21 CFR 820 (FDA Quality Management System Regulation(QMSR)), the Manufacturer is the entity that “designs, manufactures, fabricates, assembles, or processes a finished device.” Therefore, the Manufacturer of the MAD (whether a medical device manufacturer or a dental sleep practitioner manufacturing at point point of care) should be aware of the regulatory requirements for each entity as they apply.
Various aspects of 3D printing are considered during regulatory submissions and evaluations, as well as during ongoing production. These include software, material selection, product design, safety, and technical experience. At PoC, one must also consider the staff’s ability to produce a Class II medical device that is safe and effective for its intended use, as required by ISO and FDA standards. More on this obligation below.
Typically, the FDA approves or clears a final medical device, but with 3D printing, also known as additive manufacturing, the FDA also considers the materials used. This fact is an essential feature of PoC 3D printing.
In 2022, the FDA published a discussion paper regarding the regulatory and quality aspects of PoC 3D printing. Although not “law”, the paper lays out several concepts and concerns related to this emerging scenario. This topic is explored in more detail below.
The FDA defines an MDPS as “– a collection of the raw materials, software and digital files, main production equipment and post-processing (if applicable) equipment intended to be used by a healthcare provider or healthcare facility, to produce a specific type of medical device at the point of care, for treating or diagnosing their patients, or preventing or mitigating disease, or to affect a structure or function of the body. An MDPS includes the medical device it is intended to produce” 1,4. These definitions are consistent with other countries, such as Australia6 (Figure 2).
The FDA will clear materials for a specific indication for use and possibly, with a specific MDPS. The key here is that the materials, regardless of type, must be cleared for that specific indication for use. So, a resin that is cleared to make a crown may or may not be cleared for the purpose of making a mandibular advancement device. To date, and to our knowledge, no resin material has been specifically cleared for PoC MAD. If contemplating PoC for MAD, it would be wise to explore this component with the manufacturer to ensure compliance (see FDA correspondence above).